MORABITO, Nunziata
 Distribuzione geografica
Continente #
EU - Europa 9.823
NA - Nord America 7.866
AS - Asia 5.070
SA - Sud America 1.589
AF - Africa 139
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 24.501
Nazione #
US - Stati Uniti d'America 7.707
RU - Federazione Russa 5.183
SG - Singapore 2.178
CN - Cina 1.550
BR - Brasile 1.323
IE - Irlanda 1.181
SE - Svezia 1.112
DE - Germania 556
IT - Italia 530
HK - Hong Kong 513
FR - Francia 341
VN - Vietnam 273
FI - Finlandia 254
GB - Regno Unito 165
UA - Ucraina 153
IN - India 145
PL - Polonia 136
AR - Argentina 86
CA - Canada 79
TR - Turchia 55
EC - Ecuador 52
IQ - Iraq 51
BD - Bangladesh 47
MX - Messico 47
BE - Belgio 40
NL - Olanda 38
ZA - Sudafrica 34
CO - Colombia 32
VE - Venezuela 32
JP - Giappone 31
PK - Pakistan 31
AT - Austria 26
UZ - Uzbekistan 25
ES - Italia 24
CL - Cile 20
ID - Indonesia 20
MA - Marocco 20
PY - Paraguay 18
EG - Egitto 17
CI - Costa d'Avorio 16
KR - Corea 14
CZ - Repubblica Ceca 13
JO - Giordania 13
PH - Filippine 13
AE - Emirati Arabi Uniti 11
IL - Israele 11
KE - Kenya 11
LT - Lituania 11
SA - Arabia Saudita 11
UY - Uruguay 11
AU - Australia 10
AZ - Azerbaigian 10
MY - Malesia 10
DZ - Algeria 8
PE - Perù 8
TN - Tunisia 8
BG - Bulgaria 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
HN - Honduras 7
KG - Kirghizistan 7
KZ - Kazakistan 7
NG - Nigeria 7
NO - Norvegia 7
NP - Nepal 7
JM - Giamaica 6
RO - Romania 6
BH - Bahrain 5
BO - Bolivia 5
ET - Etiopia 5
GT - Guatemala 5
AL - Albania 4
EE - Estonia 4
GE - Georgia 4
IR - Iran 4
SN - Senegal 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
OM - Oman 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
CR - Costa Rica 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 24.481
Città #
Moscow 1.438
Ashburn 1.279
Dublin 1.180
Singapore 1.172
Chandler 866
Dallas 752
Nyköping 584
Beijing 525
Hong Kong 472
San Jose 434
Jacksonville 418
The Dalles 269
Munich 247
Princeton 215
Dearborn 194
Medford 171
New York 169
Messina 168
Lauterbourg 166
Los Angeles 164
Ann Arbor 156
Cambridge 131
Des Moines 128
Warsaw 122
Boardman 117
Bremen 105
São Paulo 100
Ho Chi Minh City 98
Helsinki 90
Buffalo 73
Tianjin 72
Guangzhou 63
Wilmington 61
Jinan 60
Shenyang 60
Catania 57
Hanoi 56
Turku 55
Nanjing 53
Redondo Beach 53
Frankfurt am Main 51
Orem 49
Council Bluffs 45
San Mateo 45
Rio de Janeiro 44
Santa Clara 41
Brussels 40
Houston 39
Pune 37
Belo Horizonte 36
Woodbridge 35
Seattle 34
Hebei 33
Curitiba 30
Chennai 28
Haikou 28
Zhengzhou 27
Düsseldorf 26
Nanchang 26
Taizhou 26
Hangzhou 25
Ningbo 25
Strasbourg 25
Brooklyn 24
Montreal 24
Chicago 23
Tokyo 23
Johannesburg 22
Baghdad 21
Boston 21
Tashkent 21
Brasília 19
Fuzhou 19
London 19
Nuremberg 19
Guayaquil 18
Lancaster 18
Milan 18
Shanghai 18
Denver 17
Poplar 17
Porto Alegre 17
San Francisco 17
Abidjan 16
Manchester 16
Toronto 16
Amsterdam 15
Atlanta 15
Falls Church 15
Quito 15
Rome 15
Fremont 14
Goiânia 14
Hyderabad 14
Mumbai 13
Ribeirão Preto 13
Stockholm 13
Campinas 12
Changsha 12
Lahore 12
Totale 14.023
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 292
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 237
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 226
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 225
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 223
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 220
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 220
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 216
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 214
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 214
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 209
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 208
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 206
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 201
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 197
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 195
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 192
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 191
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 188
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 188
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 187
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 187
Cardiovascular effects of raloxifene hydrochloride 182
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 182
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 181
Amylasemia in uremics: a complex interpretation 180
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 179
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 177
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 175
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 172
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 172
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 172
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 171
Association between anxiety levels and osteoporosis in postmenopausal women. 170
Anxiety levels as risk factor for osteoporosis in postmenopausal women 168
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 167
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 167
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 166
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 166
Frailty and lipid profile in elderly hospitalized patients 165
Recombinant erythropoietin and hypertension 164
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 163
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 163
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 163
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 160
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 158
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 157
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 157
Amylasemia in uremics: a complex interpretation 156
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 156
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 156
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 156
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 155
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 154
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 154
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 154
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 154
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 153
Frailty modifications and prognostic impact in older patients admitted in acute care 153
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 152
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 151
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 151
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 151
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 149
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 149
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 147
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 147
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 146
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 145
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 145
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 144
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 144
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 144
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 143
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 142
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle 141
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 140
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 140
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 140
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 140
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 140
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 140
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 139
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 139
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 139
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 138
Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure 137
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 137
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 137
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 136
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 136
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 136
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 136
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 135
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 135
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 135
Role of genetic pattern on bone mineral density in thalassemic patients 133
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 133
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 132
Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors 132
Totale 16.510
Categoria #
all - tutte 80.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202152 0 0 0 0 0 0 0 0 0 0 0 52
2021/20221.526 13 194 19 58 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024923 67 137 43 99 66 200 36 90 6 20 17 142
2024/20254.005 64 74 68 259 216 99 128 784 991 298 351 673
2025/202612.010 618 878 749 800 998 2.503 1.498 1.630 1.569 481 155 131
Totale 24.884